Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients

Agarwal K, Castells L, Mullhaupt B, et al. Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients. J Hepatol. 2018;69(3):603-607.

Publication Type:

Journal Article

Authors:

Agarwal, K.; Castells, L.; Mullhaupt, B.; et, al

Source:

J Hepatol, Volume 69, Issue 3, p.603-607 (2018)

Cited On:

Export Citation:
RIS Format
Top